InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Indivior Pharmaceuticals, Inc.

INDV Clue Score71
United States Fiscal year ends December CIK 0001625297 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Woodrow D Anderson
27 Aug 2026
Chief Accounting Officer
Buy
1,500
$35.69
$53.54K
Woodrow D Anderson
5 Aug 2026
Chief Accounting Officer
Buy
1,500
$36.28
$54.42K
Christian Heidbreder
10 Jul 2026
Chief Scientific Officer
Sold on a plan
18,586
$41.14
$764.63K
Christian Heidbreder
11 Jun 2026
Chief Scientific Officer
Sold on a plan
18,586
$38.06
$707.38K
Ryan Preblick
8 Jun 2026
Chief Financial Officer
Sold on a plan
36,000
$37.70
$1.36M
Barbara Ryan
13 Mar 2026
Director
Buy
8
$31.09
$248.68
Barbara Ryan
9 Mar 2026
Director
Buy
31
$32.56
$1.01K
Stuart A Kingsley
6 Mar 2026
Director
Buy
940
$31.87
$29.95K
David E. Wheadon
5 Jan 2026
Director
Buy
1,771
$35.39
$62.68K
Mark Stejbach
5 Jan 2026
Director
Buy
775
$35.39
$27.43K
Daniel A Ninivaggi
5 Jan 2026
Director
Buy
775
$35.39
$27.43K
Keith Humphreys
5 Jan 2026
Director
Buy
775
$35.39
$27.43K
Barbara Ryan
5 Jan 2026
Director
Buy
775
$35.39
$27.43K

What was left out

Form 4 filings counted 48
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 6,248,367
History held since 7 Jan 2026